Lance Cell Biotechnology (Guangzhou) Co., Ltd., established on 2017-09-14, The business scope includes the development and application of human stem cell technology;R&D and application of cell technology;Development of Human Gene Diagnosis and Therapy Technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Biomass Energy Technology Services;Biochemical product technology research and development;New material technology research and development;3Dprint service;Food Internet Sales(Only sell prepackaged food);food business(Only sell prepackaged food);Sales of Class I Medical Devices;Sales of Class II Medical Devices;Sales of hygiene products and single-use medical products;Health Care Services(non-medical);Traditional Chinese Medicine Health Care Services(non-medical);Nursing facility services(Does not include medical services);Remote Health Management Services;Health Consulting Services(Does not include medical services);Sports Health Service;Medical Research and Experimental Development;Engage in investment activities with own funds;Domestic trade agent;trade broker;Information Technology Consulting Services;Cosmetics Wholesale;Cosmetics Retail;Sales of electrical machinery and equipment;Sales of electronic special equipment;electronics sales;Instrument sales;Optical Instrument Sales;internet sales(Except for products that require a license for sale);Personal Internet Live Streaming Service(Need to record);Sales of electronic measuring instruments;Sales of electrical instruments and meters;Wholesale of electronic components;Production of hygiene products and single-use medical products;Health food sales;Class III medical device business;Internet Information Service for Medical Devices;Import and export;liquor business;Inspection and testing service;Internet hospital services relying on physical hospitals

Hunan Guangxiu High-tech Life Technology Co., Ltd., established on 2005-11-29, Business scope includes life science and technology field,Stem Cell and Related Technology Research,to develop,Production of related products,Sales and Consulting Services(Except for items limited by laws and regulations);Cooperation and exchange of related technologies.

Guangzhou Institutes of Biomedicine and Health (GIBH)，(simplified Chinese: 中国科学院广州生物医药与健康研究院; traditional Chinese: 中國科學院廣州生物醫藥與健康研究院; pinyin: Zhōngguó Kēxué yuan guangzhou sheng wu yi yao yu jian kang yan jiu yuan) affiliated with the Chinese Academy of Sciences, is a government-sponsored scientific research institution with independent legal jurisdiction. GIBH was established by the Chinese Academy of Sciences, Guangdong Provincial Government and Guangzhou Municipal Government. The managerial mechanism of GIBH is the responsibility of Director-General, under the authority of the board of trustees.

Shenzhen Wingor Bio-technology Co., Ltd. engages in the research and development, and production of anti-tumor biological immune cell products. It offers chimeric antigen receptor T lymphocyte, clustered regulatory interspaced short palindromic repeat, mesenchymal stem cell, methyl triazeno imidazole carboxamide technology, and cryobiomedical technology. The company was founded on March 12, 2013 and is headquartered in Shenzhen, China.

Guangzhou Saliai Stemcell Science & Technology Co., Ltd. engages in the provision of stem cell storage, health supplements, biological products, and related health management services. It involves in the production of regenerative medicine devices, medical nutrition supplements, and biological & medical cosmetic products. It operates a research and development platform which includes life bank, health management center, medical center, and medical cell center. The company was founded by Hai Jia Chen and Ming Jia Chen on July 7, 2009 and is headquartered in Guangzhou, China.

Beijing Chengnuo Medical Technology Co., Ltd., established on 2010-09-16, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Medical Research and Experimental Development;Sales of medical devices Class I;Import and export,Technology Import and Export,Agent import and export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Manufactures and sells pharmaceuticals

Part of Cellular Biomedicine Group, Inc., Shanghai Cellular Biopharmaceutical Group Ltd. is a company headquartered in China. The firm develops therapies for cancer and degenerative diseases.

Zhejiang Yimei Biotechnology Co., Ltd., established on 2016-04-11, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;R&D and application of cell technology;Information Technology Consulting Services;Health Consulting Services(Does not include medical services);Cosmetics Retail;Cosmetics Wholesale;Personal Hygiene Sales;General merchandise sales;Conference and Exhibition Services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Stratatech Corporation, a regenerative medicine company, engages in the development and commercialization of cell-based and tissue-engineered skin substitute products for therapeutic and research applications. The company specializes in human tissue substitutes generated with NIKS keratinocytes and cells derived from them for biological therapies. Its products include StrataGraft skin tissue, a temporary wound cover that promotes wound healing by the patient's own cells and improve the wound bed to receive autografts; and ExpressGraft skin tissue, a genetically enhanced tissue that produces various levels of natural wound healing and antimicrobial factors. The company was founded in 2000 and is based in Madison, Wisconsin.

Shunho Cell Biotech Tianjin Co., Ltd. is a Chinese private company located in Tianjin that engages in stem cell preparation development & clinical treatment research.

Guangdong Xtem Biotechnology Co. Ltd., part of Guangzhou Ruizhu Biological Technology Co., Ltd., is a company headquartered in China that provides investment services.

Inner Mongolia Saikexing Livestock Seed Industry and Breeding Biotechnology Research Institute Co., Ltd., established on 2015-04-28, Business scope includes animal husbandry;Breeding livestock and poultry production;Breeding livestock and poultry management;feed production;Feed additive production;Inspection and testing service;livestock sales(Does not contain dogs);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Import and export;Import and export agency;Sales of agricultural and sideline products;Animal Husbandry and Fishery Feed Sales;grass planting;Feed Additive Sales;Manufacture of specialized machinery for agriculture, forestry, animal husbandry, sideline fishery;Machinery sales;Machinery and Equipment Leasing;Veterinary special equipment sales

Suzhou Yikesai Biotechnology Co., Ltd., established on 2013-08-30, Business scope includesIproduction of medical devices:6840In vitro diagnostic reagents(serum containing medium,serum-free medium,Cytokine reagents,ELISA Kit,Sequencing library construction reagents and kits),Sales of company-produced products.engage inIIclass of medical devices,IIIWholesale of Medical Devices,Import and export business(Does not involve state-run trade and managed goods,Quota involved,of license-managed goods,Apply in accordance with the relevant regulations of the state).Provide technical services in the field of biological expertise,technology development,technical consulting,technology transfer.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hangzhou Shuoxi Bio-pharmaceutical Co., Ltd, established on 2023-01-13, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Development of Human Gene Diagnosis and Therapy Technology;Human stem cell technology development and application;Chemical product sales(No licensed chemical products);Organize cultural and artistic exchange activities;Conference and Exhibition Services;Graphic design and production;Corporate Image Planning;Industrial Design Services;Professional Design Services;Sales of Class I Medical Devices;Sales of Class II Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:pharmaceutical production;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Innovate Calgary is where startups, entrepreneurs, researchers, investors, industry and partners take innovation and ideas to business. It takes an ecosystem to drive the commercialization success of an innovation or discovery, and we are here to give you the help you need to take your startup, discovery or investment to the next stage of growth or market entry. How? It's simple, Just Ask. Innovate Calgary is the technology-transfer and business-incubation centre for the University of Calgary. Working closely with Research Services and the Office of the Vice-President (Research), we work to help bridge the gap between discovery and innovation.

Hangzhou Fengshuoda Biomedicine Co., Ltd., established on 2022-10-18, Business scope includes general items:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Development of Human Gene Diagnosis and Therapy Technology;Human stem cell technology development and application;Chemical product sales(No licensed chemical products);Organize cultural and artistic exchange activities;Conference and Exhibition Services;Graphic design and production;Corporate Image Planning;Industrial Design Services;Professional Design Services;Sales of Class I Medical Devices;Sales of Class II Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Shenzhen Kehuirui Biomedical Co., Ltd., established on 2014-02-21, Business scope includes general business items:Biological product,Pharmaceutical technology development;Invest in business(Specific projects will be reported separately);Domestic Trade(Does not contain franchise,monopoly,Specially Controlled Commodities);Operating import and export business;Information Consulting,investment management,Investment Advisory,Investment Advisor(No restricted items);Equity investment in unlisted companies;Carry out equity investment and enterprise listing consulting business(Do not publicly raise and issue funds in any way).,The licensing program is:

Ketu Medicine was established in August 2016 by Dr. Sun Zhijian, former senior researcher of BeiGene, Mr. Kang Ping, former co-founder of ACROBiosystems, and Professor Xie Dong, professor/chief scientist of the Institute of Nutrition, Chinese Academy of Sciences. founded. Ketu Medicine is the earliest domestic company focusing on the research and development and commercial transformation of organoid technology. The core team members have served in well-known pharmaceutical companies, hospitals, scientific research and CROs such as Novartis, BeiGene, GE Healthcare, Chinese Academy of Sciences, 301 Hospital, etc. service organization.

Hangzhou Jianlai Biotechnology Co., Ltd., established on 2021-01-15, Business scope includes general items:R&D and application of cell technology;Natural science research and experimental development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class II Medical Devices;Healthy food(prepackaged)Sales;Sales of infant formula milk powder and other infant formula food;Food Internet Sales(Only sell prepackaged food);food sales(Only sell prepackaged food);Sales of daily chemical products;Import and export;Sales of formula food for special medical purposes;Cosmetics Retail;Cosmetics Wholesale;internet sales(Except for products that require a license for sale);marketing planning;Information Consulting Service(Not including licensing information consulting services);Instrument sales;software development;Sales of hygiene products and single-use medical products;Sales of Class I Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).